New Zealand markets closed

Akero Therapeutics, Inc. (AKRO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
19.50+1.18 (+6.44%)
At close: 04:00PM EDT
19.21 -0.29 (-1.49%)
After hours: 06:25PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts7787
Avg. Estimate-0.94-0.98-3.94-4.23
Low estimate-1.15-1.17-4.64-4.82
High estimate-0.82-0.86-3.48-3.69
Year ago EPS-0.6-0.71-2.89-3.94
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5566
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.63-0.68-0.86-0.95
Actual EPS-0.6-0.71-0.99-0.9
Difference0.03-0.03-0.130.05
Surprise %4.80%-4.40%-15.10%5.30%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.94-0.98-3.94-4.23
7 days ago-0.94-0.98-3.94-4.23
30 days ago-0.97-1.01-3.89-4.32
60 days ago-1-1.04-3.97-4.33
90 days ago-0.93-0.97-3.53-4.21
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days3333
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesAKROIndustrySector(s)S&P 500
Current qtr.-56.70%N/AN/AN/A
Next qtr.-38.00%N/AN/AN/A
Current year-36.30%N/AN/AN/A
Next year-7.40%N/AN/AN/A
Next 5 years (per annum)-20.70%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A